Loading ......
The exosome membrane is far more than a passive wrapper around a cargo. Built as a curved lipid bilayer and studded with a distinctive set of proteins, it governs how the vesicle is recognized, where it goes, and whether its contents are delivered. Understanding the membrane is therefore central to understanding exosome biology, and it is also the feature that makes these vesicles attractive as engineered tools. This article focuses on the architecture of the exosome membrane — its lipid composition, its tetraspanin scaffold, and the ways in which membrane properties determine fusion, uptake, and targeting — and explains why reading and controlling this membrane is essential for both basic research and application.
Exosome membranes are enriched in certain lipids relative to the plasma membrane of the cell that released them. Cholesterol and sphingomyelin are concentrated in ordered microdomains, while ceramide has been linked to the budding of vesicles into the lumen of multivesicular bodies during their formation. Phosphatidylserine, normally confined to the inner leaflet of the plasma membrane, is exposed on the outer surface of many exosomes, a feature that influences how they are recognized by other cells and by clearance mechanisms. The high curvature imposed by the small diameter of the vesicle further shapes membrane behavior, affecting fluidity and the exposure of surface molecules. These lipid features are not decorative; they determine mechanical stability, the tendency to fuse with other membranes, and the lifetime of the vesicle in biological fluids. A membrane that is rich in cholesterol and sphingomyelin, for example, is more ordered and may resist premature fusion, whereas ceramide-rich regions can promote the membrane bending required for budding and release.
Figure 1. Structure and composition of exosome. (Source: Xiao L, et al. 2021)
Among the best-known exosome surface proteins are the tetraspanins, a family that includes several widely used markers such as CD9, CD63, CD81, and CD82. These molecules span the membrane four times and do not act alone; instead they organize into networks with one another and with a large set of partner proteins, forming microdomains on the vesicle surface. CD9, CD63, and CD81 are among the most consistently detected exosomal surface proteins and are commonly used together as a co-expression panel for identifying exosomes, whereas CD82 is often examined in relation to adhesion and migration-associated interactions. These tetraspanin-enriched microdomains serve as platforms that concentrate adhesion and signaling proteins, shaping how the vesicle presents itself to the external environment. The presence of particular tetraspanins is so consistent that they are routinely used to identify exosomes, yet their role is functional as well as diagnostic: by gathering other proteins into defined regions, the tetraspanin network helps determine which molecules are available to interact with target cells. Differences in the tetraspanin composition between vesicle subpopulations reflect differences in cellular origin and maturation, which is why these proteins are central both to vesicle identification and to understanding vesicle heterogeneity.
Figure 2. Tetraspanins concentrated on plasma membrane. (Source: Andreu Z, et al. 2014)
How an exosome delivers its cargo depends heavily on the properties of its membrane. Vesicles can be taken up by target cells through several routes, including direct fusion with the plasma membrane, which releases luminal content into the cytoplasm, and various forms of endocytosis, which route the vesicle through intracellular compartments. The lipid makeup of the membrane influences both pathways: membrane fluidity and curvature affect the ease of fusion, while surface proteins can engage receptors that trigger uptake. Phosphatidylserine exposure, in particular, has been associated with recognition and internalization by recipient cells. These mechanisms are not mutually exclusive, and a given vesicle population may employ more than one. The practical implication is that the membrane is the principal determinant of delivery efficiency and route, so altering membrane composition can change not only whether a vesicle reaches a cell but how its cargo is ultimately released.
Because the surface of an exosome is what other cells first encounter, the membrane also acts as the targeting interface. Surface proteins and lipids determine which receptors on a recipient cell can bind the vesicle, and therefore which tissues are preferentially reached. Integrins, intercellular adhesion molecules such as ICAM-1, and major histocompatibility complex proteins are among the surface determinants that have been linked to directing vesicles toward particular cell types, each offering a potential handle for engineering selective uptake. This natural tropism can be exploited or redirected: modifying the surface to display a targeting moiety can steer vesicles toward cells that express the corresponding receptor, an approach of clear interest for delivering therapeutic cargo to specific tissues. At the same time, the membrane's self-derived character helps vesicles avoid rapid immune clearance, extending their circulation. The dual role of the membrane — as both an address label and a protective shell — explains why so much effort in vesicle engineering focuses on the surface rather than the lumen. A vesicle whose membrane is well matched to its intended target will deliver more of its cargo where it is needed and less where it is not.
Not all exosome membranes are alike, and resolving this heterogeneity is a recurring theme in the field. Proteomic comparisons have revealed that seemingly similar vesicle preparations can be separated into subpopulations with distinct surface markers and lipid features, with proteins such as flotillin, annexin A2, and individual tetraspanins like CD63 versus CD81 marking different vesicle classes, each likely corresponding to a different biogenesis route or cellular source. Being able to distinguish these subpopulations matters because their functional properties and tissue preferences may differ substantially. Methods that characterize the membrane at the level of individual vesicles, rather than averaging across a mixed population, are increasingly important for both biological discovery and quality control of vesicle products. As our ability to read membrane heterogeneity improves, so does our ability to interpret what a given vesicle preparation represents and to design membranes with predictable behavior. The membrane, in short, is where much of the biological specificity of exosomes is encoded.
Exosomes are one member of a broader family of extracellular vesicles that also includes larger microvesicles shed directly from the plasma membrane and other release pathways, and the membranes of these populations are not identical. Microvesicles tend to retain more of the plasma membrane's composition and can expose different surface proteins, whereas exosomes inherit the specialized lipid and protein environment of the multivesicular body from which they arise. These distinctions matter because mixed vesicle preparations behave as a blend of subpopulations, and the membrane features responsible for targeting or fusion may belong disproportionately to one subtype. Efforts to separate vesicle classes by size, density, or surface marker have therefore become central to interpreting membrane data. Recognizing that a given membrane property may be specific to a vesicle subclass, rather than to extracellular vesicles as a whole, prevents overgeneralization and helps attribute function to the correct population.
References
| Target | Cat. No. | Product Name | Expression System | Tag/Conjugate | Application | |
| Exosome | DAGA-987 | Purified exosomes from plasma of healthy donors | Plasma of healthy donors | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry |
| DAGA-988 | Purified exosomes from urine of healthy donors | Urine of healthy donors | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-989 | Purified exosomes from COLO1 cell culture supernatant | Human Colon Carcinoma cell line COLO1 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-990 | Purified exosomes from MM1 cell culture supernatant | Human Melanoma cell line MM1 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-991 | Purified exosomes from BLCL cell culture supernatant | BLCL21 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-992 | Purified exosomes from HCT116 cell culture supernatant | Human Colon Carcinoma cell line HCT116 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-993 | Purified exosomes from U87 MG cell culture supernatant | Human Glioblastoma-Astrocytoma cell line U87 MG | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-994 | Purified exosomes from SK-N-SH cell culture supernatant | Human Neuroblastoma cell line SK-N-SH | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-995 | Purified exosomes from PC3 cell culture supernatant | Human Prostate adenocarcinoma grade IV cell line PC3 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-996 | Purified exosomes from BPH-1 cell culture supernatant | Human being prostatic hyperplasia cell line BPH-1 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-997 | Purified exosomes from DAUDI cell culture supernatant | Human Burkitt Lymphoma cell line DAUDI | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-998 | Purified exosomes from A549 cell culture supernatant | Lung carcinoma cell line A549 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-999 | Purified exosomes from K562 cell culture supernatant | Pleural effusion, leukemia chronic myelogenous cell line K562 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-1000 | Purified exosomes from B16F10 mouse cell culture supernatant | Mouse melanoma cell line B16F10 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-1001 | Purified exosomes from serum of healthy donors | Serum of healthy donors | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-1002 | Purified exosomes from saliva of healthy donors | Saliva of healthy donors | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-1003 | Fluorescent labeled Exosome Standards | N/A | FITC | Fluorescence microscopy, Flow cytometry, EM | Inquiry | |
| DAG-WT3255 | Purified exosomes from HEK293 cell line | HEK293 cells | N/A | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAG-WT1158 | Purified exosomes from MSC | MSC from Adipose tissue | N/A | Calibration, Control, Flow cytometry, EM | Inquiry |
Loading ......